目次

Table of Contents

1. Executive Summary

2. Neurodegenerative Disorder Therapeutics Market Characteristics

3. Neurodegenerative Disorder Therapeutics Market Trends And Strategies

4. Impact Of COVID-19 On Neurodegenerative Disorder Therapeutics

5. Neurodegenerative Disorder Therapeutics Market Size And Growth
5.1. Global Neurodegenerative Disorder Therapeutics Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Neurodegenerative Disorder Therapeutics Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Neurodegenerative Disorder Therapeutics Market Segmentation
6.1. Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Parkinson's Disease
Alzheimer's Disease
Multiple Sclerosis
Huntington Disease
Other Indication Types
6.2. Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
N- methyl- D- aspartate Receptor
Selective Serotonin Reuptake Inhibitor
Dopamine Inhibitors
Other Drug Types
6.3. Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Distribution, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

7. Neurodegenerative Disorder Therapeutics Market Regional And Country Analysis
7.1. Global Neurodegenerative Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Neurodegenerative Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Neurodegenerative Disorder Therapeutics Market
8.1. Asia-Pacific Neurodegenerative Disorder Therapeutics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8.3. Asia-Pacific Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Neurodegenerative Disorder Therapeutics Market
9.1. China Neurodegenerative Disorder Therapeutics Market Overview
9.2. China Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
9.3. China Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Neurodegenerative Disorder Therapeutics Market
10.1. India Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
10.2. India Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Neurodegenerative Disorder Therapeutics Market
11.1. Japan Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11.2. Japan Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Neurodegenerative Disorder Therapeutics Market
12.1. Australia Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12.2. Australia Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Neurodegenerative Disorder Therapeutics Market
13.1. Indonesia Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13.2. Indonesia Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Neurodegenerative Disorder Therapeutics Market
14.1. South Korea Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14.2. South Korea Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Neurodegenerative Disorder Therapeutics Market
15.1. Western Europe Neurodegenerative Disorder Therapeutics Market Overview
15.2. Western Europe Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15.3. Western Europe Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Neurodegenerative Disorder Therapeutics Market
16.1. UK Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16.2. UK Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Neurodegenerative Disorder Therapeutics Market
17.1. Germany Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17.2. Germany Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Neurodegenerative Disorder Therapeutics Market
18.4. France Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18.5. France Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Neurodegenerative Disorder Therapeutics Market
19.1. Eastern Europe Neurodegenerative Disorder Therapeutics Market Overview
19.2. Eastern Europe Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19.3. Eastern Europe Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Neurodegenerative Disorder Therapeutics Market
20.1. Russia Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20.2. Russia Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Neurodegenerative Disorder Therapeutics Market
21.1. North America Neurodegenerative Disorder Therapeutics Market Overview
21.2. North America Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21.3. North America Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Neurodegenerative Disorder Therapeutics Market
22.1. USA Neurodegenerative Disorder Therapeutics Market Overview
22.2. USA Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22.3. USA Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Neurodegenerative Disorder Therapeutics Market
23.1. South America Neurodegenerative Disorder Therapeutics Market Overview
23.2. South America Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23.3. South America Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Neurodegenerative Disorder Therapeutics Market
24.1. Brazil Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24.2. Brazil Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Neurodegenerative Disorder Therapeutics Market
25.1. Middle East Neurodegenerative Disorder Therapeutics Market Overview
25.2. Middle East Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25.3. Middle East Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Neurodegenerative Disorder Therapeutics Market
26.1. Africa Neurodegenerative Disorder Therapeutics Market Overview
26.2. Africa Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26.3. Africa Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Neurodegenerative Disorder Therapeutics Market Competitive Landscape And Company Profiles
27.1. Neurodegenerative Disorder Therapeutics Market Competitive Landscape
27.2. Neurodegenerative Disorder Therapeutics Market Company Profiles
27.2.1. Biogen
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Pfizer
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Novartis
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Sanofi
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Teva Pharmaceutical
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Neurodegenerative Disorder Therapeutics Pipeline Analysis

29. Key Mergers And Acquisitions In The Neurodegenerative Disorder Therapeutics Market

30. Neurodegenerative Disorder Therapeutics Market Future Outlook and Potential Analysis

31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. The Business Research Company
31.5. Copyright And Disclaimer

List of Tables
Table 1: Global Historic Market Growth, 2016-2021, $ Billion
Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Table 3: Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 4: Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 5: Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Distribution, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 6: Global Neurodegenerative Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 7: Global Neurodegenerative Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 8: Asia-Pacific, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 9: Asia-Pacific, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 10: China, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 11: China, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 12: India, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 13: India, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 14: Japan, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 15: Japan, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 16: Australia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 17: Australia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 18: Indonesia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 19: Indonesia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 20: South Korea, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 21: South Korea, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 22: Western Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 23: Western Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 24: UK, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 25: UK, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 26: Germany, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 27: Germany, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 28: France, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 29: France, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 30: Eastern Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 31: Eastern Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 32: Russia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 33: Russia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 34: North America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 35: North America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 36: USA, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 37: USA, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 38: South America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 39: South America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 40: Brazil, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 41: Brazil, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 42: Middle East, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 43: Middle East, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 44: Africa, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 45: Africa, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 46: Biogen Financial Performance
Table 47: Pfizer Financial Performance
Table 48: Novartis Financial Performance
Table 49: Sanofi Financial Performance
Table 50: Teva Pharmaceutical Financial Performance

List of Figures
Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Figure 3: Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 4: Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 5: Global Neurodegenerative Disorder Therapeutics Market, Segmentation By Distribution, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 6: Global Neurodegenerative Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 7: Global Neurodegenerative Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 8: Asia-Pacific, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 9: Asia-Pacific, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 10: China, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 11: China, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 12: India, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 13: India, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 14: Japan, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 15: Japan, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 16: Australia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 17: Australia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 18: Indonesia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 19: Indonesia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 20: South Korea, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 21: South Korea, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 22: Western Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 23: Western Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 24: UK, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 25: UK, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 26: Germany, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 27: Germany, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 28: France, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 29: France, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 30: Eastern Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 31: Eastern Europe, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 32: Russia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 33: Russia, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 34: North America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 35: North America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 36: USA, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 37: USA, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 38: South America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 39: South America, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 40: Brazil, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 41: Brazil, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 42: Middle East, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 43: Middle East, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 44: Africa, Neurodegenerative Disorder Therapeutics Market, Segmentation By Indication Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 45: Africa, Neurodegenerative Disorder Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 46: Biogen Financial Performance
Figure 47: Pfizer Financial Performance
Figure 48: Novartis Financial Performance
Figure 49: Sanofi Financial Performance
Figure 50: Teva Pharmaceutical Financial Performance